A&A Szeligasp. z o.o.

Real estate agencies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-04-30
Share capital
5,000.00 PLN
Registered address
ul. Kornela Makuszyńskiego 95, 44-310 Radlin, Poland
Electronic delivery address
AE:PL-19204-68108-CWFWJ-32

Financials

Revenue history

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 77 days late).

  • 2025filed
  • 202430/06/2025
  • 202330/06/2024
  • 202230/06/2023
  • 202130/09/2022
  • 202030/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Real estate agencies2,161 / 2,273
Top 95%
Division · Real estate activities17,322 / 18,729
Top 92%
City · Radlin50 / 53
Top 94%
Voivodeship · Śląskie31,384 / 33,279
Top 94%
Country · Poland279,978 / 297,935
Top 94%

Results vs industry

Revenue
This companyUSD 779.15MedianUSD 48.94kAverageUSD 315.93k
Net profit
This companyUSD -65.61MedianUSD 1.97kAverageUSD 32.90k
Operating costs
This companyUSD 844.76MedianUSD 43.14kAverageUSD 264.31k
Assets
This companyUSD 1.92kMedianUSD 34.26kAverageUSD 485.32k

Authorized Representatives

Adrian Adam Szeliga – President of the Management Board
Anna Agnieszka Szeliga – Vice President of the Management Board

Manner of representation

Each member of the management board is authorised to submit declarations of will on behalf of the company and to represent the company independently.

Ownership

OwnerSharesShare valueStake
Adrian Adam Szeligaage 40
30$810.3760%
Anna Agnieszka Szeligaage 39
20$540.2540%

Adrian Adam Szeliga and Anna Agnieszka Szeliga hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

FAQ

Last updated: 2026-04-12